Heart failure & cardiomyopathies
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER
Study context
- Population
- Participants, sites and staff of the DELIVER trial (dapagliflozin in HF with preserved EF) during the COVID-19 pandemic
Methodological detailslarge, global registrational CV trial
- Large, global registrational CV trial
Primary result
As reported in the abstract
- Ensuring delivery of study medications
- Adaptations to study visits
- Enhanced COVID-19-related endpoint adjudication
- Protocol and analytical plan revisions
Original publication
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER. Am Heart J. Published 21 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →